BamSEC and AlphaSense Join Forces
Learn More

Surrozen Inc.

NASDAQ: SRZN    
Share price (12/23/24): $12.23    
Market cap (12/23/24): $39.7 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 9 pages First Amendment to Lease
12/34/56
EX-10.1
from 10-Q 19 pages This Sublease (This "Sublease") Is Dated for Reference Purposes as of April 16, 2024, and Is Made by and Between Surrozen Operating, Inc., a Delaware Corporation ("Sublessor"), and Nura Bio, Inc., a Delaware Corporation ("Sublessee"). Sublessor and Sublessee Hereby Agree as Follows
12/34/56
EX-10.5
from 10-K 14 pages Surrozen, Inc. 2021 Employee Stock Purchase Plan Adopted by the Board of Directors: August 14, 2021 Approved by the Stockholders: August 10, 2021 Adjusted for (1:15) Reverse Stock Split: December 13, 2023
12/34/56
EX-10.3
from 10-K 33 pages Surrozen, Inc. Stock Option Grant Notice
12/34/56
EX-10.2
from 10-K 30 pages Surrozen, Inc. 2021 Equity Incentive Plan Adopted by the Board of Directors: August 14, 2021 Approved by the Stockholders: August 10, 2021 Adjusted for (1:15) Reverse Stock Split: December 13, 2023
12/34/56
EX-10.7
from 8-K 23 pages Surrozen, Inc. Registration Rights Agreement
12/34/56
EX-10.6
from 8-K 15 pages Series D Common Stock Warrant Surrozen, Inc
12/34/56
EX-10.5
from 8-K 15 pages Series C Common Stock Warrant Surrozen, Inc
12/34/56
EX-10.4
from 8-K 15 pages Series B Common Stock Warrant Surrozen, Inc
12/34/56
EX-10.3
from 8-K 15 pages Series a Common Stock Warrant Surrozen, Inc
12/34/56
EX-10.2
from 8-K 14 pages Pre-Funded Common Stock Warrant Surrozen, Inc
12/34/56
EX-10.1
from 8-K 39 pages Surrozen, Inc. Securities Purchase Agreement
12/34/56
EX-10.2
from 10-Q 4 pages Charles River Laboratories, Inc. 251 Ballardvale Street Wilmington, Massachusetts 01887 Distributed Bio, Inc. 329 Oyster Point Blvd., 3rd Floor South San Francisco, Ca 94080 September 20, 2023 Re: Antibody Library Subscription Agreement Between Surrozen Operating, Inc. and Charles River Laboratories Inc. (Successor-In-Interest to Distributed Bio, Inc), Dated September 30, 2016, as Amended Dear Sir or Madam
12/34/56
EX-10.1
from 10-Q 11 pages Surrozen, Inc. Restricted Stock Unit Grant Notice
12/34/56
EX-10.1
from 8-K 7 pages 171 Oyster Point Blvd., Suite 400 South San Francisco, Ca 94080 July 18, 2023 1. Separation. Your Last Day of Work With the Company and Your Employment Termination Date Will Be July 31, 2023 (The “Separation Date”). 2
12/34/56
EX-10
from 10-Q 4 pages Side Agreement No. 2 Relating to the Exclusive Agreement Between Surrozen Operating, Inc. and the Board of Trustees of the Leland Stanford Junior University, Dated March 23, 2016, as Amended
12/34/56
EX-10.1
from 10-Q 85 pages Certain Confidential Information Contained in This Document, Marked by Brackets, Is Filed With the Securities and Exchange Commission Pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as Amended. Collaboration and License Agreement by and Between Boehringer Ingelheim International Gmbh Binger Strasse 173, 55216 Ingelheim Am Rhein and Surrozen Operating, Inc. 171 Oyster Point Blvd., Suite 400, South San Francisco, Ca 94080 Bi Contract No: 43105378
12/34/56
EX-10.3
from 10-Q 27 pages Non-Exclusive License Agreement for Wnt Modulating Antibodies Identified From Llama Single Domain Antibody Phage
12/34/56
EX-10.20
from 10-K 47 pages Lease the Cove at Oyster Point Hcp Oyster Point III LLC, a Delaware Limited Liability Company as Landlord, and Surrozen, Inc., a Delaware Corporation, as Tenant
12/34/56
EX-10.2
from 8-K 16 pages Registration Rights Agreement
12/34/56